News & Events

DPS Welcome Brian Duffy as Senior Director of Engineering and Architecture

Tuesday 27 October 2020

DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, today announced that Brian Duffy has joined the firm as senior director of engineering and architecture for Boston project operations. Reporting to Paul DePriest, senior vice president for Boston Project operations, Brian will be responsible for the consistent and coordinated execution of engineering and architecture project deliverables. In this role, he will manage and coordinate the cross-discipline interaction between managers with a focus on developing talent and providing innovative and technical solutions.

“Under Brian’s direction, we will build on our strong reputation as an innovative EPCMV firm through the further development of subject matter experts, building information modelling (BIM) capabilities, and discipline bench strength,” said Paul. “Brian worked at a global life science firm for over 20 years which provides invaluable experience in the leadership of an engineering and design team.   

Brian brings over 20 years of experience in the biotechnology industry in the areas of process design engineering, large capital project execution, biotech manufacturing support engineering, and team leadership. Brian held multiple positions at Sanofi Genzyme, including as the design and engineering lead for an integrated continuous biomanufacturing facility (ICBF), associate director of process engineering, and senior process engineer. He has also held positions at Pfizer (Wyeth), Massachusetts Biologic Laboratories at the UMass Medical School, and Alkermes, Inc.

Brian earned a Bachelor of Science in microbiology from the University of Massachusetts in Amherst and a Master of Science in mechanical engineering from Tufts University. He is a member of the International Society for Professional Engineers (ISPE).

Back to top
DPS Group addresses the COVID-19 pandemic:
A message from Frank Keogh, CEO

Find out more Contact Us